🔎 Trials Near Me

Home › Breast Diseases › Texas

Breast Diseases clinical trials in Texas

7 studies for Breast Diseases are looking for participants at sites in Texas.

Cities in Texas

ATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE) - iSono Health

  • Cypress Innovative Breast Care Center, Cypress
RecruitingObservational study
Ages 18 to 94 · Women · Updated Sep 17, 2026 · NCT07505797

Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer

  • University of Texas MD Anderson Cancer Center, Houston
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT05386108

A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer

  • Research Site, Fort Worth
  • Research Site, Kingwood
RecruitingPhase 3
Ages 18 to 130 · All sexes · Updated Sep 8, 2026 · NCT07647328

IMPACT: Improving Maternal Postpartum Access to Care Through Telemedicine

  • Parkland Hospital, Dallas
RecruitingHealthy volunteers welcome
Ages 18 and older · Women · Updated Sep 2, 2026 · NCT06218355

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

  • Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas
  • University of Texas Southwestern, Dallas
  • University of Texas MD Anderson Cancer Center, Houston
  • and 1 more
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jul 7, 2026 · NCT05768139

Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors

  • The University of Texas MD Anderson Cancer Center, Houston
  • START, San Antonio
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jun 23, 2026 · NCT06993844

Hormones, Outcomes, and Pain Pathways in Exercise Study

  • University of Houston, Houston
RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 60 · Women · Updated Jun 2, 2026 · NCT07579182

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.